{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:35:07Z","timestamp":1792154107784,"version":"4.4.0"},"reference-count":104,"publisher":"Impact Journals, LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2023,5,15]]},"DOI":"10.18632\/aging.204698","type":"journal-article","created":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T16:20:35Z","timestamp":1683994835000},"page":"3295-3330","source":"Crossref","is-referenced-by-count":8,"title":["Proteostatic modulation in brain aging without associated Alzheimer\u2019s disease-and age-related neuropathological changes"],"prefix":"10.18632","volume":"15","author":[{"given":"Pol","family":"Andr\u00e9s-Benito","sequence":"first","affiliation":[{"name":"Neurologic Diseases and Neurogenetics Group - Bellvitge Institute for Biomedical Research (IDIBE LL), L\u2019Hospitalet de Llobregat, Barcelona 08907, Spain"},{"name":"CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, L\u2019Hospitalet de Llobregat, Barcelona 08907, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"\u00cd\u00f1igo-Marco","sequence":"additional","affiliation":[{"name":"Clinical Neuroproteomics Unit, Proteomics Platform, Proteored-ISCIII, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad P\u00fablica de Navarra (UPNA), diSNA, Pamplona 31008, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Brullas","sequence":"additional","affiliation":[{"name":"CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, L\u2019Hospitalet de Llobregat, Barcelona 08907, Spain"},{"name":"Neuropathology Group, Institute of Biomedical Research, IDIBELL, L\u2019Hospitalet de Llobregat, Barcelona 08907, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Carmona","sequence":"additional","affiliation":[{"name":"CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, L\u2019Hospitalet de Llobregat, Barcelona 08907, Spain"},{"name":"Neuropathology Group, Institute of Biomedical Research, IDIBELL, L\u2019Hospitalet de Llobregat, Barcelona 08907, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio del","family":"Rio","sequence":"additional","affiliation":[{"name":"CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, L\u2019Hospitalet de Llobregat, Barcelona 08907, Spain"},{"name":"Molecular and Cellular Neurobiotechnology Group, Institute of Bioengineering of Catalonia (IBEC), Barcelona Institute for Science and Technology, Science Park Barcelona (PCB), Barcelona 08028, Spain"},{"name":"Department of Cell Biology, Physiology and Immunology, Faculty of Biology, University of Barcelona, Barcelona 08007, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Fern\u00e1ndez-Irigoyen","sequence":"additional","affiliation":[{"name":"Clinical Neuroproteomics Unit, Proteomics Platform, Proteored-ISCIII, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad P\u00fablica de Navarra (UPNA), diSNA, Pamplona 31008, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Santamar\u00eda","sequence":"additional","affiliation":[{"name":"Clinical Neuroproteomics Unit, Proteomics Platform, Proteored-ISCIII, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad P\u00fablica de Navarra (UPNA), diSNA, Pamplona 31008, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Povedano","sequence":"additional","affiliation":[{"name":"Neurologic Diseases and Neurogenetics Group - Bellvitge Institute for Biomedical Research (IDIBE LL), L\u2019Hospitalet de Llobregat, Barcelona 08907, Spain"},{"name":"CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, L\u2019Hospitalet de Llobregat, Barcelona 08907, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidro","family":"Ferrer","sequence":"additional","affiliation":[{"name":"CIBERNED (Network Centre of Biomedical Research of Neurodegenerative Diseases), Institute of Health Carlos III, L\u2019Hospitalet de Llobregat, Barcelona 08907, Spain"},{"name":"Neuropathology Group, Institute of Biomedical Research, IDIBELL, L\u2019Hospitalet de Llobregat, Barcelona 08907, Spain"},{"name":"Department of Pathology and Experimental Therapeutics, University of Barcelona, L\u2019Hospitalet de Llobregat, Barcelona 08907, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2023,5,13]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.17879\/freeneuropathology-2022-3806","article-title":"Alzheimer\u2019s disease is an inherent, natural part of human brain aging: an integrated perspective.","volume":"3","author":"Ferrer","year":"2022","journal-title":"Free Neuropathology"},{"key":"2","doi-asserted-by":"publisher","first-page":"e13122","DOI":"10.1111\/bpa.13122","article-title":"Hypothesis review: Alzheimer's overture guidelines.","volume":"3","author":"Ferrer","year":"2023","journal-title":"Brain Pathol"},{"key":"3","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/1615-9861(200111)1:12%3c1519::aid-prot1519%3e3.0.co;2-l","article-title":"Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process.","volume":"1","author":"Cooper","year":"2001","journal-title":"Proteomics"},{"key":"4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1559-0275-10-5","article-title":"Semiquantitative proteomic analysis of human hippocampal tissues from Alzheimer's disease and age-matched control brains.","volume":"1","author":"Diamandis","year":"2013","journal-title":"Clin Proteomics"},{"key":"5","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1021\/pr401202d","article-title":"Quantification of the brain proteome in Alzheimer's disease using multiplexed mass spectrometry.","volume":"1","author":"Shevchenko","year":"2014","journal-title":"J Proteome Res"},{"key":"6","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jalz.2015.11.002","article-title":"Profiling the human hippocampal proteome at all pathologic stages of Alzheimer's disease.","volume":"1","author":"Smit","year":"2016","journal-title":"Alzheimers Dement"},{"key":"7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.exger.2015.11.016","article-title":"Temporal lobe in human aging: A quantitative protein profiling study of samples from Chinese Human Brain Bank.","volume":"7","author":"Ma","year":"2016","journal-title":"Exp Gerontol"},{"key":"8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/ana.25266","article-title":"Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia.","volume":"8","author":"Smith","year":"2018","journal-title":"Ann Neurol"},{"key":"9","doi-asserted-by":"publisher","first-page":"180036","DOI":"10.1038\/sdata.2018.36","article-title":"Global quantitative analysis of the human brain proteome in Alzheimer\u2019s and Parkinson\u2019s Disease.","volume":"5","author":"Seyfried","year":"2018","journal-title":"Sci Data"},{"key":"10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41597-020-00650-8","article-title":"Global quantitative analysis of the human brain proteome and phosphoproteome in Alzheimer's disease.","volume":"7","author":"Seyfried","year":"2020","journal-title":"Sci Data"},{"key":"11","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1021\/acs.jproteome.9b00004","article-title":"Proteomic Atlas of the Human Brain in Alzheimer's Disease.","volume":"1","author":"Coon","year":"2019","journal-title":"J Proteome Res"},{"key":"12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13041-019-0430-y","article-title":"Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer's disease.","volume":"1","author":"Sze","year":"2019","journal-title":"Mol Brain"},{"key":"13","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/s41467-019-09613-z","article-title":"Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age.","volume":"1","author":"Seyfried","year":"2019","journal-title":"Nat Commun"},{"key":"14","doi-asserted-by":"publisher","first-page":"104509","DOI":"10.1016\/j.nbd.2019.104509","article-title":"Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease.","volume":"13","author":"Rezeli","year":"2019","journal-title":"Neurobiol Dis"},{"key":"15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41588-020-00773-z","article-title":"Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer's disease pathogenesis.","volume":"5","author":"Lah","year":"2021","journal-title":"Nat Genet"},{"key":"16","doi-asserted-by":"publisher","first-page":"eabi8178","DOI":"10.1126\/sciadv.abi8178","article-title":"A brain proteomic signature of incipient Alzheimer's disease in young APOE \u03b54 carriers identifies novel drug targets.","volume":"7","author":"Moaddel","year":"2021","journal-title":"Sci Adv"},{"key":"17","doi-asserted-by":"publisher","first-page":"750665","DOI":"10.3389\/fimmu.2021.750665","article-title":"Topological Dissection of Proteomic Changes Linked to the Limbic Stage of Alzheimer's Disease.","volume":"1","author":"Rezeli","year":"2021","journal-title":"Front Immunol"},{"key":"18","doi-asserted-by":"publisher","first-page":"e13047","DOI":"10.1111\/bpa.13047","article-title":"Proteomic analysis of human hippocampal subfields provides new insights into the pathogenesis of Alzheimer's disease and the role of glial cells.","volume":"3","author":"Ma","year":"2022","journal-title":"Brain Pathol"},{"key":"19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes.","volume":"8","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/s0197-4580(97)00056-0","article-title":"Frequency of stages of Alzheimer-related lesions in different age categories.","volume":"1","author":"Braak","year":"1997","journal-title":"Neurobiol Aging"},{"key":"21","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.","volume":"7","author":"Del Tredici","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"key":"22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.pneurobio.2012.03.005","article-title":"Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia.","volume":"9","author":"Ferrer","year":"2012","journal-title":"Prog Neurobiol"},{"key":"23","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1093\/brain\/awv236","article-title":"The preclinical phase of the pathological process underlying sporadic Alzheimer's disease.","volume":"13","author":"Del Tredici","year":"2015","journal-title":"Brain"},{"key":"24","first-page":"1","article-title":"Neuroanatomy and pathology of sporadic Alzheimer's disease.","volume":"21","author":"Del Tredici","year":"2015","journal-title":"Adv Anat Embryol Cell Biol"},{"key":"25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/alz.12192","article-title":"Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease.","volume":"1","author":"Braak","year":"2021","journal-title":"Alzheimers Dement"},{"key":"26","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/s0968-0004(00)01712-6","article-title":"The regulation of protein function by multisite phosphorylation--a 25 year update.","volume":"2","author":"Cohen","year":"2000","journal-title":"Trends Biochem Sci"},{"key":"27","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1021\/cr000225s","article-title":"Structural basis for control by phosphorylation.","volume":"10","author":"Lewis","year":"2001","journal-title":"Chem Rev"},{"key":"28","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1126\/science.1075762","article-title":"The protein kinase complement of the human genome.","volume":"29","author":"Sudarsanam","year":"2002","journal-title":"Science"},{"key":"29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nrm759","article-title":"Phosphotyrosine-binding domains in signal transduction.","volume":"3","author":"Yaffe","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pbiomolbio.2009.06.004","article-title":"Bistability by multiple phosphorylation of regulatory proteins.","volume":"10","author":"Nov\u00e1k","year":"2009","journal-title":"Prog Biophys Mol Biol"},{"key":"31","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1111\/j.1742-4658.2009.07027.x","article-title":"Multisite protein phosphorylation--from molecular mechanisms to kinetic models.","volume":"27","author":"H\u00f6fer","year":"2009","journal-title":"FEBS J"},{"key":"32","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.jprot.2011.03.033","article-title":"Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects.","volume":"7","author":"Butterfield","year":"2011","journal-title":"J Proteomics"},{"key":"33","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/j.1471-4159.2012.07737.x","article-title":"Phosphoproteome profiling of substantia nigra and cortex regions of Alzheimer's disease patients.","volume":"12","author":"Ahmed","year":"2012","journal-title":"J Neurochem"},{"key":"34","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/pmic.201400171","article-title":"Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome.","volume":"1","author":"Peng","year":"2015","journal-title":"Proteomics"},{"key":"35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JAD-150417","article-title":"Quantitative phosphoproteomic analyses of the inferior parietal lobule from three different pathological stages of Alzheimer's disease.","volume":"4","author":"Butterfield","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"36","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/pmic.201400189","article-title":"Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins.","volume":"1","author":"Seyfried","year":"2015","journal-title":"Proteomics"},{"key":"37","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.neuron.2019.12.015","article-title":"Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer's Disease Progression.","volume":"10","author":"Han","year":"2020","journal-title":"Neuron"},{"key":"38","doi-asserted-by":"publisher","first-page":"e12996","DOI":"10.1111\/bpa.12996","article-title":"Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer's disease.","volume":"3","author":"Santamar\u00eda","year":"2021","journal-title":"Brain Pathol"},{"key":"39","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1089\/omi.2019.0191","article-title":"Multiplexed Phosphoproteomic Study of Brain in Patients with Alzheimer's Disease and Age-Matched Cognitively Healthy Controls.","volume":"2","author":"Pandey","year":"2020","journal-title":"OMICS"},{"key":"40","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/bpa.12593","article-title":"Aging-related tau astrogliopathy (ARTAG): not only tau phosphorylation in astrocytes.","volume":"2","author":"Sabido","year":"2018","journal-title":"Brain Pathol"},{"key":"41","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00401-019-02122-9","article-title":"Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy.","volume":"13","author":"Del Rio","year":"2020","journal-title":"Acta Neuropathol"},{"key":"42","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1002\/pmic.201200415","article-title":"Phosphoproteome analysis of an early onset mouse model (TgCRND8) of Alzheimer's disease reveals temporal changes in neuronal and glia signaling pathways.","volume":"1","author":"Zou","year":"2013","journal-title":"Proteomics"},{"key":"43","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1021\/pr4005103","article-title":"Longitudinal study of differential protein expression in an Alzheimer's mouse model lacking inducible nitric oxide synthase.","volume":"1","author":"Colton","year":"2013","journal-title":"J Proteome Res"},{"key":"44","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/hmg\/ddu475","article-title":"Comprehensive phosphoproteome analysis unravels the core signaling network that initiates the earliest synapse pathology in preclinical Alzheimer's disease brain.","volume":"2","author":"Iwatsubo","year":"2015","journal-title":"Hum Mol Genet"},{"key":"45","doi-asserted-by":"publisher","first-page":"33627","DOI":"10.18632\/oncotarget.9092","article-title":"An integrated proteomics approach shows synaptic plasticity changes in an APP\/PS1 Alzheimer's mouse model.","volume":"7","author":"Larsen","year":"2016","journal-title":"Oncotarget"},{"key":"46","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1021\/acschemneuro.9b00190","article-title":"Changes of Protein Phosphorylation Are Associated with Synaptic Functions during the Early Stage of Alzheimer's Disease.","volume":"1","author":"Chen","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"47","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/jnen\/nlac062","article-title":"Dysregulated Protein Phosphorylation in a Mouse Model of FTLD-Tau.","volume":"8","author":"Santamar\u00eda","year":"2022","journal-title":"J Neuropathol Exp Neurol"},{"key":"48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease.","volume":"7","author":"Jones","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"49","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000354370","article-title":"Rate of conversion from prodromal Alzheimer's disease to Alzheimer's dementia: a systematic review of the literature.","volume":"3","author":"Arrighi","year":"2013","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"50","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1212\/WNL.0000000000004826","article-title":"Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.","volume":"9","author":"Rae-Grant","year":"2018","journal-title":"Neurology"},{"key":"51","doi-asserted-by":"publisher","first-page":"101916","DOI":"10.1016\/j.arr.2023.101916","article-title":"The unique neuropathological vulnerability of the human brain to aging.","volume":"8","author":"I","year":"2023","journal-title":"Ageing Res Rev"},{"key":"52","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3233\/JAD-2010-100162","article-title":"Changed clathrin regulatory proteins in the brains of Alzheimer's disease patients and animal models.","volume":"2","author":"Guan","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"53","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.brainres.2010.10.003","article-title":"Human Ermin (hErmin), a new oligodendrocyte-specific cytoskeletal protein related to epileptic seizure.","volume":"136","author":"Zhang","year":"2011","journal-title":"Brain Res"},{"key":"54","doi-asserted-by":"publisher","first-page":"5659","DOI":"10.1038\/ncomms6659","article-title":"The role of protein clearance mechanisms in organismal ageing and age-related diseases.","volume":"5","author":"Dillin","year":"2014","journal-title":"Nat Commun"},{"key":"55","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2174\/138920291501140306113344","article-title":"The Mechanistic Links Between Proteasome Activity, Aging and Age-related Diseases.","volume":"1","author":"Vilchez","year":"2014","journal-title":"Curr Genomics"},{"key":"56","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41467-019-13906-8","article-title":"The proteasome 19S cap and its ubiquitin receptors provide a versatile recognition platform for substrates.","volume":"1","author":"Matouschek","year":"2020","journal-title":"Nat Commun"},{"key":"57","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.4049\/jimmunol.152.3.1163","article-title":"MHC-encoded proteasome subunits LMP2 and LMP7 are not required for efficient antigen presentation.","volume":"15","author":"Bennink","year":"1994","journal-title":"J Immunol"},{"key":"58","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.1073\/pnas.1322079111","article-title":"Understanding the mechanism of proteasome 20S core particle gating.","volume":"11","author":"Kay","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"59","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3389\/fnagi.2016.00303","article-title":"Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative Diseases.","volume":"8","author":"Wang","year":"2016","journal-title":"Front Aging Neurosci"},{"key":"60","doi-asserted-by":"publisher","first-page":"187","DOI":"10.4172\/2157-7609.1000187","article-title":"Ubiquitin-Proteasome System in Neurodegenerative Disorders.","volume":"6","author":"Awasthi","year":"2015","journal-title":"J Drug Metab Toxicol"},{"key":"61","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41418-020-00706-7","article-title":"Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities.","volume":"2","author":"Dewson","year":"2021","journal-title":"Cell Death Differ"},{"key":"62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arcmed.2020.09.007","article-title":"Proteasome Subunits Involved in Neurodegenerative Diseases.","volume":"5","author":"Reynaud","year":"2021","journal-title":"Arch Med Res"},{"key":"63","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3389\/fendo.2018.00790","article-title":"Hallmarks of Aging: An Autophagic Perspective.","volume":"9","author":"Fader","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"64","doi-asserted-by":"publisher","first-page":"238463","DOI":"10.1155\/2014\/238463","article-title":"Mitochondrial aging and age-related dysfunction of mitochondria.","volume":"201","author":"Bobryshev","year":"2014","journal-title":"Biomed Res Int"},{"key":"65","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2174\/1381612822666161230144517","article-title":"New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.","volume":"2","author":"Morris","year":"2017","journal-title":"Curr Pharm Des"},{"key":"66","doi-asserted-by":"publisher","first-page":"11391","DOI":"10.3390\/ijms231911391","article-title":"Mitochondrial DNA Repair in Neurodegenerative Diseases and Ageing.","volume":"2","author":"Vascotto","year":"2022","journal-title":"Int J Mol Sci"},{"key":"67","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2016.06.023","article-title":"PPAR\u03b3 as a therapeutic target to rescue mitochondrial function in neurological disease.","volume":"10","author":"Duchen","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"68","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bbadis.2009.10.007","article-title":"Mitochondria: a therapeutic target in neurodegeneration.","volume":"180","author":"Smith","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"69","doi-asserted-by":"publisher","first-page":"101018","DOI":"10.1016\/j.mam.2021.101018","article-title":"Molecular targets and approaches to restore autophagy and lysosomal capacity in neurodegenerative disorders.","volume":"8","author":"Nyfeler","year":"2021","journal-title":"Mol Aspects Med"},{"key":"70","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/S1474-4422(18)30238-2","article-title":"Selective autophagy as a potential therapeutic target for neurodegenerative disorders.","volume":"1","author":"Cuervo","year":"2018","journal-title":"Lancet Neurol"},{"key":"71","doi-asserted-by":"publisher","first-page":"381","DOI":"10.14348\/molcells.2015.0034","article-title":"Autophagy in neurodegenerative diseases: from mechanism to therapeutic approach.","volume":"3","author":"Jung","year":"2015","journal-title":"Mol Cells"},{"key":"72","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bpa.12545","article-title":"Autophagy in neurodegenerative diseases: pathogenesis and therapy.","volume":"2","author":"Le","year":"2018","journal-title":"Brain Pathol"},{"key":"73","doi-asserted-by":"publisher","first-page":"118664","DOI":"10.1016\/j.bbamcr.2020.118664","article-title":"Glycogen synthase kinase-3 signaling in Alzheimer's disease.","volume":"186","author":"Pratic\u00f2","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"74","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1365-2990.2006.00795.x","article-title":"Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration.","volume":"3","author":"Brion","year":"2007","journal-title":"Neuropathol Appl Neurobiol"},{"key":"75","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.neulet.2006.09.026","article-title":"Age-related changes in glycogen synthase kinase 3beta (GSK3beta) immunoreactivity in the central nervous system of rats.","volume":"40","author":"Cha","year":"2006","journal-title":"Neurosci Lett"},{"key":"76","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/npp.2015.285","article-title":"Upregulation of GSK3\u03b2 Contributes to Brain Disorders in Elderly REG\u03b3-knockout Mice.","volume":"4","author":"Li","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"77","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1093\/gerona\/glt210","article-title":"Effects of lithium on age-related decline in mitochondrial turnover and function in Caenorhabditis elegans.","volume":"6","author":"Gunawan","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"78","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1074\/jbc.M705028200","article-title":"Pharmacogenetic analysis of lithium-induced delayed aging in Caenorhabditis elegans.","volume":"28","author":"Lithgow","year":"2008","journal-title":"J Biol Chem"},{"key":"79","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/acel.12418","article-title":"Regional metabolic heterogeneity of the hippocampus is nonuniformly impacted by age and caloric restriction.","volume":"1","author":"Anderson","year":"2016","journal-title":"Aging Cell"},{"key":"80","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11357-019-00085-z","article-title":"An expanding GSK3 network: implications for aging research.","volume":"4","author":"Anderson","year":"2019","journal-title":"Geroscience"},{"key":"81","doi-asserted-by":"publisher","first-page":"5408452","DOI":"10.1155\/2020\/5408452","article-title":"Proteomic Profile of Mouse Brain Aging Contributions to Mitochondrial Dysfunction, DNA Oxidative Damage, Loss of Neurotrophic Factor, and Synaptic and Ribosomal Proteins.","volume":"202","author":"Yang","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"82","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.3390\/cells10082021","article-title":"Quantitative Proteomics Reveals Significant Differences between Mouse Brain Formations in Expression of Proteins Involved in Neuronal Plasticity during Aging.","volume":"1","author":"Rakus","year":"2021","journal-title":"Cells"},{"key":"83","doi-asserted-by":"publisher","first-page":"6188","DOI":"10.3390\/ijms22126188","article-title":"Absolute Proteome Analysis of Hippocampus, Cortex and Cerebellum in Aged and Young Mice Reveals Changes in Energy Metabolism.","volume":"2","author":"Rakus","year":"2021","journal-title":"Int J Mol Sci"},{"key":"84","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/j.1471-4159.1993.tb03611.x","article-title":"A tau fragment containing a repetitive sequence induces bundling of actin filaments.","volume":"6","author":"Maccioni","year":"1993","journal-title":"J Neurochem"},{"key":"85","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1021\/bi981874p","article-title":"Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments.","volume":"3","author":"Mandelkow","year":"1999","journal-title":"Biochemistry"},{"key":"86","doi-asserted-by":"publisher","first-page":"15733","DOI":"10.1074\/jbc.M000389200","article-title":"Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments.","volume":"27","author":"Brandt","year":"2000","journal-title":"J Biol Chem"},{"key":"87","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/jcb.10133","article-title":"Tubulin, actin, and tau protein interactions and the study of their macromolecular assemblies.","volume":"8","author":"Maccioni","year":"2002","journal-title":"J Cell Biochem"},{"key":"88","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/iub.1384","article-title":"Microtubule-associated proteins as direct crosslinkers of actin filaments and microtubules.","volume":"6","author":"John","year":"2015","journal-title":"IUBMB Life"},{"key":"89","doi-asserted-by":"publisher","first-page":"725241","DOI":"10.3389\/fcell.2021.725241","article-title":"Tau and Membranes: Interactions That Promote Folding and Condensation.","volume":"9","author":"Vander Zanden","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"90","doi-asserted-by":"publisher","first-page":"653815","DOI":"10.3389\/fcell.2021.653815","article-title":"Role of the Lipid Membrane and Membrane Proteins in Tau Pathology.","volume":"9","author":"Kim","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"91","doi-asserted-by":"publisher","first-page":"e12813","DOI":"10.7554\/eLife.12813","article-title":"Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases.","volume":"5","author":"Fell","year":"2016","journal-title":"Elife"},{"key":"92","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s10571-019-00780-7","article-title":"Quantitative Phosphoproteomic Analysis in Alpha-Synuclein Transgenic Mice Reveals the Involvement of Aberrant p25\/Cdk5 Signaling in Early-stage Parkinson's Disease.","volume":"4","author":"Zhang","year":"2020","journal-title":"Cell Mol Neurobiol"},{"key":"93","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1007\/s12035-021-02698-y","article-title":"Quantitative Phosphoproteomics Reveals Extensive Protein Phosphorylation Dysregulation in the Cerebral Cortex of Huntington's Disease Mice Prior to Onset of Symptoms.","volume":"5","author":"Renoir","year":"2022","journal-title":"Mol Neurobiol"},{"key":"94","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.15252\/embj.201591593","article-title":"Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1","volume":"3","author":"Itzen","year":"2015","journal-title":"EMBO J"},{"key":"95","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/s41467-021-21211-6","article-title":"Robust inference of kinase activity using functional networks.","volume":"1","author":"Koyut\u00fcrk","year":"2021","journal-title":"Nat Commun"},{"key":"96","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1021\/pr101065j","article-title":"Andromeda: a peptide search engine integrated into the MaxQuant environment.","volume":"1","author":"Mann","year":"2011","journal-title":"J Proteome Res"},{"key":"97","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","article-title":"The Perseus computational platform for comprehensive analysis of (prote)omics data.","volume":"1","author":"Cox","year":"2016","journal-title":"Nat Methods"},{"key":"98","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1038\/s41596-021-00566-6","article-title":"Tutorial: best practices and considerations for mass-spectrometry-based protein biomarker discovery and validation.","volume":"1","author":"Evans-Molina","year":"2021","journal-title":"Nat Protoc"},{"key":"99","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1002\/pmic.201600044","article-title":"Multiple testing corrections in quantitative proteomics: A useful but blunt tool.","volume":"1","author":"Haynes","year":"2016","journal-title":"Proteomics"},{"key":"100","doi-asserted-by":"publisher","first-page":"D1107","DOI":"10.1093\/nar\/gkw1080","article-title":"jPOSTrepo: an international standard data repository for proteomes.","volume":"4","author":"Ishihama","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"101","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.","volume":"1","author":"Chanda","year":"2019","journal-title":"Nat Commun"},{"key":"102","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","article-title":"An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex.","volume":"3","author":"Zhang","year":"2014","journal-title":"J Neurosci"},{"key":"103","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1038\/nn.4160","article-title":"Cell type- and brain region-resolved mouse brain proteome.","volume":"1","author":"Simons","year":"2015","journal-title":"Nat Neurosci"},{"key":"104","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: a graphical gene-set enrichment tool for animals and plants.","volume":"3","author":"Yao","year":"2020","journal-title":"Bioinformatics"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204698","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T12:19:44Z","timestamp":1684757984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,13]]},"references-count":104,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,5,15]]}},"alternative-id":["204698","37179123"],"URL":"https:\/\/doi.org\/10.18632\/aging.204698","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,13]]}}}